Synergy reports positive results from Phase IIb/III chronic idiopathic constipation trial
Synergy Pharmaceuticals has reported positive results from Phase IIb/III trial of plecanatide in patients with chronic idiopathic constipation (CIC).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Constipation | Pharmaceuticals